OSTX Other Current Liab from 2010 to 2024

OSTX Stock   3.02  1.44  32.29%   
OS Therapies Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities will likely drop to about 3.4 M in 2024. During the period from 2010 to 2024, OS Therapies Other Current Liabilities regression line of annual values had r-squared of  0.43 and arithmetic mean of  2,035,102. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
4.7 M
Current Value
3.4 M
Quarterly Volatility
936 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 1 M or Total Revenue of 0.0, as well as many indicators such as . OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of OS Therapies Incorporated over the last few years. It is OS Therapies' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

OSTX Other Current Liab Regression Statistics

Arithmetic Mean2,035,102
Geometric Mean1,899,607
Coefficient Of Variation45.99
Mean Deviation676,876
Median1,612,054
Standard Deviation935,988
Sample Variance876.1B
Range3.1M
R-Value0.66
Mean Square Error536.9B
R-Squared0.43
Significance0.01
Slope137,385
Total Sum of Squares12.3T

OSTX Other Current Liab History

20243.4 M
20234.7 M
2022M

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities4.7 M3.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.